Alvesco for the Therapy of Persistent Asthma With or Without Allergic Component
Alvesco for the Therapy of Persistent Asthma With or Without Allergic Component
The aim of the study is to evaluate the efficacy of Alvesco in patients with persistent asthma including or excluding allergic components over 3 months, especially in the spring season. Alvesco will be inhaled by a metered-dose inhaler. The study will provide further data on safety and tolerability of Alvesco .
Main Inclusion Criteria:
Main Exclusion Criteria:
Gr. Siegharts, 3812, Austria
Graz-Gösting, 8051, Austria
Kirchdorf and Der Krems, 4560, Austria
Klein-Pöchlam, 3660, Austria
Saint Johann I. Pg., 5600, Austria
St.Georgen i.A., 4880, Austria
Waidhofen/Thaya, 3830, Austria